Eterna Therapeutics Inc. (NASDAQ: ERNA)
$2.08
-0.0100 ( -0.48% ) 1.1K
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Market Data
Open
$2.08
Previous close
$2.09
Volume
1.1K
Market cap
$11.25M
Day range
$1.98 - $2.11
52 week range
$0.84 - $2.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 12 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
3 | Insider transactions | 2 | Jan 03, 2024 |
8-k | 8K-related | 19 | Dec 20, 2023 |
4 | Insider transactions | 1 | Dec 20, 2023 |
4 | Insider transactions | 1 | Dec 18, 2023 |
8-k | 8K-related | 13 | Dec 14, 2023 |
8-k | 8K-related | 13 | Nov 16, 2023 |
10-q | Quarterly Reports | 76 | Nov 13, 2023 |